Half-year report · Q2

Period2024-07-01 → 2024-12-31
Filed2025-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥5.2bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥2.8bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income−¥203m2024-07-01 → 2024-12-31Cons.Operating income
Operating income−¥455m2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income−¥198m2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥566m2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥449m2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax−¥212m2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥449m2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)−¥222m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥662m2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥488m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income−¥222m2024-07-01 → 2024-12-31Cons.Profit loss
Net income−¥489m2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥6.6bnat 2024-12-31Cons.Assets
Total assets¥6.9bnat 2024-06-30Cons.Assets
Total assets¥7.1bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥557mat 2024-12-31Cons.Liabilities
Total liabilities¥697mat 2024-06-30Cons.Liabilities
Net assets / equity¥6.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥6.2bnat 2024-06-30Cons.Net assets
Net assets / equity¥6.4bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.6bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥4.8bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥4.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.8bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow¥98m2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥881m2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥967m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥324m2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥14m2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥10m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥172,0002024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥261m2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥260m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-8.52024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.322023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.652023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio91.3%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.7%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 50
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥14m
Reconciling Itemsreconcilingrevenue external2024-07-01 → 2024-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥15m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥159m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥152m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥19m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥751m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31¥25m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2024-07-01 → 2024-12-31¥1.2bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥4m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2024-07-01 → 2024-12-31−¥132m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2024-07-01 → 2024-12-31¥183m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2024-07-01 → 2024-12-31¥173m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥11m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2024-07-01 → 2024-12-31¥3m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2024-07-01 → 2024-12-31¥393m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2024-07-01 → 2024-12-31¥39m
—segment totalrevenue2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue external2024-07-01 → 2024-12-31¥2.7bn
—segment totalrevenue intersegment2024-07-01 → 2024-12-31¥15m
—segment totalsegment profit2024-07-01 → 2024-12-31−¥45m
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥10m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2023-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥11m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥156m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥72m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥270m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2023-12-31¥165m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥157m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥8m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2023-12-31−¥701,000
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥43m
—segment totalrevenue2023-07-01 → 2023-12-31¥2.9bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥2.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥11m
—segment totalsegment profit2023-07-01 → 2023-12-31−¥299m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Depreciation and amortization ope cfPrior1YTDDuration12925000JPY
Depreciation and amortization ope cfCurrentYTDDuration7772000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-31000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-JPY
Increase decrease in provision for loss on order received ope cfPrior1YTDDuration-5072000JPY
Increase decrease in provision for loss on order received ope cfCurrentYTDDuration-JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration-1515000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration1655000JPY
Interest income ope cfPrior1YTDDuration-31000JPY
Interest income ope cfCurrentYTDDuration-598000JPY
Compensation income for damage ope cfPrior1YTDDuration-3719000JPY
Compensation income for damage ope cfCurrentYTDDuration-1930000JPY
Loss on closing of office ope cfPrior1YTDDuration-JPY
Loss on closing of office ope cfCurrentYTDDuration14300000JPY
Loss gain on sales of noncurrent assets ope cfPrior1YTDDuration134000JPY
Loss gain on sales of noncurrent assets ope cfCurrentYTDDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-389385000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-50837000JPY
Decrease increase in inventories ope cfPrior1YTDDuration203195000JPY
Decrease increase in inventories ope cfCurrentYTDDuration182845000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration53127000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration67722000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-279247000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-59139000JPY
Increase decrease in contract liabilities ope cfPrior1YTDDuration-11372000JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration-58270000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-11968000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration13886000JPY
Other net ope cfPrior1YTDDuration-117929000JPY
Other net ope cfCurrentYTDDuration26143000JPY
Subtotal ope cfPrior1YTDDuration-1000315000JPY
Subtotal ope cfCurrentYTDDuration-68895000JPY
Interest income received ope cfPrior1YTDDuration28000JPY
Interest income received ope cfCurrentYTDDuration445000JPY
Compensation for damage received ope cfPrior1YTDDuration3719000JPY
Compensation for damage received ope cfCurrentYTDDuration1930000JPY
Payments of loss on workplace closing ope cfPrior1YTDDuration-JPY
Payments of loss on workplace closing ope cfCurrentYTDDuration-14300000JPY
Income taxes paid refund ope cfPrior1YTDDuration29790000JPY
Income taxes paid refund ope cfCurrentYTDDuration178423000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration-966777000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration97602000JPY
Purchase of short term investment securities inv cfPrior1YTDDuration-JPY
Purchase of short term investment securities inv cfCurrentYTDDuration-300000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-6851000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-23825000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-3081000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-685000JPY
Proceeds from collection of guarantee deposits inv cfPrior1YTDDuration-JPY
Proceeds from collection of guarantee deposits inv cfCurrentYTDDuration546000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass